Bioaffinity Technologies Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Bioaffinity Technologies Inc 's ROA in the second quarter of 2026?
Bioaffinity Technologies Inc recorded a cumulative net loss of $-15 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -159.54%.

However, within the Healthcare sector 815 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4458, from total ROA ranking in the first quarter of 2026 at 5157.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	60.37 %	43.23 %	68.27 %	76.23 %	-28.62 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-15	-16	-15	-15	-12
Return On Assets (TTM)	-159.54 %	-180.44 %	-181.8 %	-207.9 %	-200.12 %
BIAF's Total Ranking	# 4458	# 5157	# 4602	# 4677	# 4678
Total Assets (TTM) in million	8	8	11	12	5
Seq. Total Assets Change	-4.1 %	-27.51 %	-5.07 %	143.03 %	-14.35 %
Seq. Net Income Change	-	-	-	-	-

BIAF's 5 Years Annual ROA >> Back to BIAF Management Effectiveness >> Compare BIAF ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 36
Sector	# 816
Overall	# 4370

Return On Assets Statistics
High	Average	Low
-69.42 %	-137.14 %	-207.9 %
(Sep 30 2023)		(Sep 30 2025)

News about Bioaffinity Technologies Inc Return on Assets ROA

Market Turmoil Hits BioAffinity Technologies Understanding the Recent Stock Sell-Off and Future Potential

BioAffinity Technologies Inc (BIAF): Analyzing the Recent Sell-Off Amid Market ConcernsBioAffinity Technologies Inc (NASDAQ: BIAF) recently experienced a significant sell-off, leading to its shares now trading at $1.73. This is a stark contrast to its performance earlier in the year, where it had outperformed the market, supported by a series of favorable developments and a 217% sales growth in its CyPath Lung product for Q2 2024. However, as of August 3, 2024, BIAF shares find themselves 52.21% below their 52-week high, although they remain 81.19% above their 52-week low. Such data suggests a highly volatile trading environment for BioAffinity Technologies, reflecting investor sentiment amidst shifting market dynamics. Recent Market Behaviors Impacting BioAffinity Technologies1. Market Volatility and External Factors : The backdrop of the recent sell-off can be attributed to broader market volatility. Notably, on August 2, the CSIMarket.com Industrial Average dipped over 400 points, reflecting uncertainty and bearish sentiment among investors. Asian markets did not fare better, with Japan s Nikkei 225 losing 5.81%, and major Chinese indices following suit. The apprehensive global market environment may create a risk-off attitude among investors, leading them to cash out from stocks like BioAffinity Technologies that, despite their growth potential, are presently facing downward price pressure.

Financial Statements
Bioaffinity Technologies Inc 's Assets	$ 8 million	BIAF's Balance sheet
Bioaffinity Technologies Inc 's Income	$ -3 million	Quarterly BIAF's Income Statement
BIAF's Income by Division		See BIAF's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	FY
Y / Y Total Assets Change	68.27 %	-20.77 %	-32.51 %	-	-
Total Assets in million	11	7	8	12	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-15	-9	-8	-8	0
Annual Return On Assets	-136.03 %	-138.78 %	-96.54 %	-66.94 %	-

BIAF's 5 Years Annual ROA >> Back to BIAF Management Effectiveness >> Compare BIAF ROA to its Competitors

More Return On Assets Ratios
BIAF's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BIAF's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BIAF's Competitors
Subscribers only: Roa for Bioaffinity Technologies Inc 's Suppliers
Subscribers only: Return On Assets for BIAF's Customers

You may also want to know
BIAF's Roi	BIAF's Inventory Turnover Ratio	BIAF's Growth Rates	BIAF's Dividend Comparisons
	BIAF's Profitability Ratios	BIAF's Asset Turnover Ratio	BIAF's Dividend Growth
BIAF's Roe	BIAF's Valuation Ratios	BIAF's Financial Strength Ratios	BIAF's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T06:26:48+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.